
Prince Akwasi Mensah
Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )
| Most Active Art Unit | 2474 |
| Art Unit(s) | 2416, 2474 |
| Total Applications | 590 |
| Issued Applications | 431 |
| Pending Applications | 63 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5057699
[patent_doc_number] => 20070060621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Methods and compositions for the administration of prodrugs of proton pump inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/554151
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6171
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554151 | Methods and compositions for the administration of prodrugs of proton pump inhibitors | Jan 12, 2005 | Abandoned |
Array
(
[id] => 680369
[patent_doc_number] => 07084174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Administration of isovaleryl L-carnitine to stimulate osteoblastic activity'
[patent_app_type] => utility
[patent_app_number] => 11/032019
[patent_app_country] => US
[patent_app_date] => 2005-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1918
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/084/07084174.pdf
[firstpage_image] =>[orig_patent_app_number] => 11032019
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/032019 | Administration of isovaleryl L-carnitine to stimulate osteoblastic activity | Jan 10, 2005 | Issued |
Array
(
[id] => 7040646
[patent_doc_number] => 20050159453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Novel methods for the treatment and prevention of ileus'
[patent_app_type] => utility
[patent_app_number] => 11/024097
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14225
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11024097
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/024097 | Novel methods for the treatment and prevention of ileus | Dec 27, 2004 | Abandoned |
Array
(
[id] => 6906176
[patent_doc_number] => 20050101571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Methods of treating cancer using a combination of drugs'
[patent_app_type] => utility
[patent_app_number] => 11/012621
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5800
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101571.pdf
[firstpage_image] =>[orig_patent_app_number] => 11012621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/012621 | Methods of treating cancer using a combination of drugs | Dec 15, 2004 | Abandoned |
Array
(
[id] => 5029048
[patent_doc_number] => 20070270495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Use of Cystine or Cysteine for the Prevention and Treatment of Oxidative Stress Cause by Haemodialysis and of Acute or Chronic Kidney Diseases'
[patent_app_type] => utility
[patent_app_number] => 10/583334
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1160
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270495.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583334 | Method for treating hemodialysis-related oxidative stress using cystine or cysteine | Dec 15, 2004 | Issued |
Array
(
[id] => 6906148
[patent_doc_number] => 20050101543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Treatments for neurogenetic disorders, impulse control disorders, and wound healing'
[patent_app_type] => utility
[patent_app_number] => 11/013259
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10273
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013259 | Treatments for neurogenetic disorders, impulse control disorders, and wound healing | Dec 14, 2004 | Abandoned |
Array
(
[id] => 4989500
[patent_doc_number] => 20070155841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Preventive agent for carcinogenesis of liver cancer containing quinone-based compound as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/596945
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2400
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596945 | Preventive agent for carcinogenesis of liver cancer containing quinone-based compound as active ingredient | Dec 13, 2004 | Abandoned |
Array
(
[id] => 7145827
[patent_doc_number] => 20050119297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Use of 5HT3 agonists for relaxing the fundus'
[patent_app_type] => utility
[patent_app_number] => 11/010590
[patent_app_country] => US
[patent_app_date] => 2004-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1311
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119297.pdf
[firstpage_image] =>[orig_patent_app_number] => 11010590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/010590 | Use of 5HT3 agonists for relaxing the fundus | Dec 12, 2004 | Abandoned |
Array
(
[id] => 5005591
[patent_doc_number] => 20070203163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Novel Treatment Of Irritable Bowel Syndrome 1'
[patent_app_type] => utility
[patent_app_number] => 10/582388
[patent_app_country] => US
[patent_app_date] => 2004-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1973
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203163.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582388 | Novel Treatment Of Irritable Bowel Syndrome 1 | Dec 7, 2004 | Abandoned |
Array
(
[id] => 5080327
[patent_doc_number] => 20070123551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders'
[patent_app_type] => utility
[patent_app_number] => 10/582182
[patent_app_country] => US
[patent_app_date] => 2004-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2240
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123551.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582182
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582182 | Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders | Dec 6, 2004 | Abandoned |
Array
(
[id] => 7173302
[patent_doc_number] => 20050203163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/004635
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8327
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203163.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004635
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004635 | Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer | Dec 2, 2004 | Abandoned |
Array
(
[id] => 7075362
[patent_doc_number] => 20050148630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Methods of preventing and treating non-opioid induced gastrointestinal dysfunction'
[patent_app_type] => utility
[patent_app_number] => 10/998793
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14063
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10998793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/998793 | Methods of preventing and treating non-opioid induced gastrointestinal dysfunction | Nov 28, 2004 | Abandoned |
Array
(
[id] => 7105166
[patent_doc_number] => 20050107346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity'
[patent_app_type] => utility
[patent_app_number] => 10/994639
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11427
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994639
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994639 | N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity | Nov 22, 2004 | Abandoned |
Array
(
[id] => 5819925
[patent_doc_number] => 20060024238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Compositions and methods using proton pump inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/988586
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11830
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024238.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988586
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988586 | Compositions and methods using proton pump inhibitors | Nov 15, 2004 | Abandoned |
Array
(
[id] => 7163747
[patent_doc_number] => 20050085551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Bupropion to treat viral diseases'
[patent_app_type] => utility
[patent_app_number] => 10/980282
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3177
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085551.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980282
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980282 | Bupropion to treat viral diseases | Nov 3, 2004 | Abandoned |
Array
(
[id] => 5023538
[patent_doc_number] => 20070149504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Use of neurokinin antagonists in the treatment of urinary incontinence'
[patent_app_type] => utility
[patent_app_number] => 10/576052
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3559
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576052 | Use of neurokinin antagonists in the treatment of urinary incontinence | Oct 25, 2004 | Issued |
Array
(
[id] => 6991494
[patent_doc_number] => 20050090531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'MAG expression promoters'
[patent_app_type] => utility
[patent_app_number] => 10/969885
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7057
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10969885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/969885 | MAG expression promoters | Oct 21, 2004 | Issued |
Array
(
[id] => 6918771
[patent_doc_number] => 20050096332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Use of tyrosine kinase inhibitors for the treatment of inflammatory processes'
[patent_app_type] => utility
[patent_app_number] => 10/967396
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3294
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096332.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967396 | Use of tyrosine kinase inhibitors for the treatment of inflammatory processes | Oct 17, 2004 | Abandoned |
Array
(
[id] => 7117201
[patent_doc_number] => 20050070502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Composition and method for the treatment of dysglucaemia'
[patent_app_type] => utility
[patent_app_number] => 10/953453
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6994
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10953453
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/953453 | Composition and method for the treatment of dysglucaemia | Sep 29, 2004 | Abandoned |
Array
(
[id] => 7117302
[patent_doc_number] => 20050070603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Use of glycerides to alleviate symptoms of digestive disorders'
[patent_app_type] => utility
[patent_app_number] => 10/951204
[patent_app_country] => US
[patent_app_date] => 2004-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1328
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070603.pdf
[firstpage_image] =>[orig_patent_app_number] => 10951204
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/951204 | Use of glycerides to alleviate symptoms of digestive disorders | Sep 26, 2004 | Abandoned |